Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 30 Nov 2020  |  Global

    Analysing Sepsis Management Part II: Treatments

    Recent developments in Sepsis Treatment focused towards antibiotics, inhibitors, antibodies, peptides, recombinant proteins, antibacterial, antifungal, antivirals, vaccines, and probiotics

    Sepsis is a life-threatening condition caused by overactivation of host immune system upon infections which may lead to organ failure and potentially death. World Health Organization designates sepsis as a global public health priority. Several studies conducted to understand the molecular basis of sepsis, septic shock, and organ failure. Despite e...

    $4,950.00
  2. 30 Nov 2020  |  Europe

    Investment in Genomics, Advanced Therapies, and Precision Health Offers New Opportunities for the UK MedTech Market

    Innovation Culture in the Life Sciences Sector Enables Growth Despite the Short-term Impact of COVID-19 and Brexit

    The United Kingdom (UK) medical technology (MedTech) market is experiencing a transformational phase. Although it achieved steady growth up to 2019 and was infused with investments as part of the UK Life Sciences Sector Deal, market and regulatory challenges persist. In this research study, Frost & Sullivan analyzes the UK MedTech market landscape ...

    $4,950.00
  3. 17 Nov 2020  |  North America

    Business Models Focusing on Patient Centricity Driving Incremental Value in the Global Digital Patient Engagement Solutions Market, 2025

    Growth Strategies to Revolve Around Value-based Care and Population Health Management Initiatives

    Healthcare is evolving, more so after the Coronavirus 2019 (COVID-19) pandemic that hit us in the beginning of 2020. Over time, we have seen surveys that indicate that patients want more control of their healthcare and be active participants of their treatment decisions. Innovations in technology and recent developments in the healthcare ecosystem ...

    $4,950.00
  4. 12 Nov 2020  |  South Asia, Middle East & North Africa

    Strategic Public-Private Partnerships Transforming the Telehealth Market in the KSA and the UAE, 2020–2025

    Future Growth Potential of Country-level Telehealth Initiatives that Create Multimillion-dollar Growth Opportunities

    In this research service, Frost & Sullivans transformational health team provides critical insights into the KSA and UAE telehealth markets and highlights growth opportunities, revenue segments, and technology trends that influence growth and revenue. The telehealth market covered in this study includes three segments: virtual visits, mHealth, and...

    $4,950.00
  5. 03 Nov 2020  |  North America

    Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020

    A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

    Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...

    $4,950.00
  6. 30 Oct 2020  |  North America

    Frost Radar™: Home-based Ophthalmic Monitoring Solutions, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Eye diseases such as glaucoma, age-related macular degeneration, diabetic retinopathy, and macular edema require continuous monitoring of eye health, as they can be treated if detected early, but if left undetected, it can silently and rapidly progress to irreversible loss of vision. Home-based ophthalmic monitoring solutions can help in preventin...

    $4,950.00
  7. 29 Oct 2020  |  Global

    Frost Radar™:Transformative Influenza Vaccines, 2020

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Influenza causes respiratory diseases and often leads to large epidemics. Every year about 290,000 to 650,000 people die due to influenza worldwide. Anti-viral drugs available to treat influenza have many limitations making vaccination the most effective tool to prevent seasonal and pandemic influenza outbreaks. Influenza vaccination is highly reco...

    $4,950.00
  8. 29 Oct 2020  |  North America

    Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025

    Increased Competitive Intensity Driving Transformational Growth through M&A, Innovative Business Models, and New Product Development

    Hemodynamic monitoring aims to guide medical management of critically ill patients who are prone to hemodynamic instability. It performs the function of assessing the blood volume and oxygen perfusion, along with other parameters, to prevent or treat organ failure and improve the outcomes for patients. This study aims to analyze and forecast the m...

    $4,950.00
  9. 23 Oct 2020  |  Global

    Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

    Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

    The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

    $4,950.00
  10. 23 Oct 2020  |  North America

    Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

    Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

    In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

    $4,950.00